Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shega versus permethrin for head lice in Ethiopian schoolchildren
PACTR202208887378021Not yet recruiting
- Sponsor
- Antenna Foundation
- Start
- Oct 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of permethrin in pediculosis capitis (2 arms), sponsored by Antenna Foundation. Primary endpoint: Primary efficacy endpoint. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
permethrin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on PACTR202208887378021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208887378021.